Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | FFAR2 | O15552 | 15/20 | 0.60 |
| ▸ | ACE | P12821 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10979196 | 0.87 | ACE (0.77) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11185062 | 0.87 | ACE (0.77) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL10969779 | 0.87 | ACE (0.77) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11191543 | 0.87 | ACE (0.77) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11191933 | 0.86 | ACE (0.58) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11195371 | 0.85 | ACE (0.73) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11257852 | 0.84 | ACE (0.55) | LMNAFFAR2ACEALDH1A1POLB | |
| SCHEMBL11188945 | 0.83 | ACE (0.71) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11184392 | 0.82 | ACE (0.69) | LMNAFFAR2ACEHTTALDH1A1 | |
| SCHEMBL11191745 | 0.82 | ACE (0.69) | LMNAFFAR2ACEHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4410542-A | HYPOTENSIVE AGENTS, PYRROLINE-1,2-DICARBOXYLIC ACID DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4347371-A | HYPERTENSIVE AGENTS; ANTIDIABETIC AGENTS; VISION DEFECTS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1982-08-31 | — | — | US | disclosed |